KRKseniya A. Rzaeva

Kseniya A. Rzaeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kseniya A. Rzaeva has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical and endovascular treatment methods for aortic coarctation in patients of different age groups (literature review)

    by S. A. Magbulova, K. A. Rzaeva, A. V. Voitov, E. N. Amansakhatova, I. A. Soynov, С. А. Магбулова, К. А. Рзаева, А. В. Войтов, Е. Н. Амансахатова, И. А. Сойнов

    Introduction. Coarctation of the aorta (CoA) remains one of the most common congenital heart defects, associated with a high incidence of cardiovascular complications even after successful correction. Despite advances in both endovascular and surgical repair techniques, there is no unified approach to selecting the optimal treatment strategy, and the available data on long-term postoperative outcomes require systematic synthesis. Aim: To analyze current data on the surgical and endovascular treatment of CoA in patients of different age groups, to characterize the anatomical features of the congenital defect, the technical aspects of interventions, immediate and long-term treatment outcomes, as well as to assess the incidence of complications and reinterventions. Material and Methods. A literature search was performed using the electronic databases eLibrary.ru and PubMed. The study included articles published between 2014 and 2026. A total of 1,331 publications on aortic coarctation were screened. Ultimately, 52 studies were included in the final review. Results. Analysis of the included publications showed that surgical correction remains the “gold standard” in neonates and young children, whereas endovascular repair is preferred in adolescents and adults. In the long term, neither of these strategies completely eliminates risks: the potential for arterial hypertension, recoarctation, aneurysm formation, and the need for repeat interventions persists. Conclusion. The choice of treatment strategy for aortic coarctation should be individualized, taking into account the patient's age, the anatomy of the narrowing, and the technical capabilities of the medical center. However, all patients, regardless of the correction method, require lifelong dynamic follow-up with regular blood pressure monitoring and aortic imaging for timely detection and management of long-term postoperative complications.

  • Open Access

    Early discontinuation of dual antiplatelet therapy after PCI in patients at high bleeding risk: an OCT-guided clinical case

    by A. A. Prokhorikhin, Yu. V. Kukushkina, D. D. Zubarev, A. V. Gorbatykh, K. A. Rzaeva, А. А. Прохорихин, Ю. В. Кукушкина, Д. Д. Зубарев, А. В. Горбатых, К. А. Рзаева

    Background. Optimizing the duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains challenging, especially in patients with high bleeding risk and diabetes mellitus, where stent thrombosis risk is significantly increased due to delayed endothelialization. Objective. To demonstrate the safety of early DAPT discontinuation based on individual assessment of stent endothelialization using optical coherence tomography (OCT). Materials and Methods. We present a clinical case of a 71-year-old female with type II diabetes, atrial fibrillation (CHA2DS2-VASc score of 6), functional class II exertional angina, and a history of left anterior descending (LAD) artery stenting. Risk stratification indicated a high hemorrhagic status: HAS-BLED score of 3, PRECISE-DAPT score of 17, ARC-HBR score of 2, and a CRUSADE score of 49 (corresponding to an 11.9 % risk of major bleeding). Baseline OCT revealed significant narrowing: the minimal lumen area in the LAD was 3.51 mm² (56 % area stenosis), and 2.08 mm² in the right coronary artery (RCA) (72 % area stenosis). Stenting of LAD and right coronary artery was performed using amphilimus-eluting polymer-free stents. DAPT discontinuation was planned at 1 month contingent on sufficient endothelialization per control OCT. Results. Follow-up OCT at one month demonstrated neointimal coverage of 81.18 % of the struts in the LAD and 95.9 % in the RCA. No evidence of stent thrombosis or restenosis was observed. The patient was transitioned to clopidogrel monotherapy, alongside ongoing anticoagulant therapy for the prevention of thrombotic complications associated with atrial fibrillation. During the one-year follow-up period, no ischemic or hemorrhagic adverse events were registered, and there was no recurrence of angina symptoms. Conclusion. The application of OCT for the evaluation of stent strut endothelialization provides a robust rationale for shortening DAPT duration to 1 month in patients with high hemorrhagic risk. This strategy minimizes bleeding threats without escalating the incidence of ischemic events, even in the presence of concomitant diabetes mellitus and multiple comorbidities.

  • Open Access

    EVOLUTION OF CORONARY STENTS: FROM EARLY EXPERIMENTS TO MODERN TECHNOLOGIES

    by Polina A. Kuznetsova, Artem V. Gorbatykh, Ksenia A. Rzaeva, Alexey A. Prokhorikhin, Ekaterina P. Kolesova, Alexey L. Maslyansky, Yana G. Toropova, Yuriy A. Skorik, Mikhail M. Galagudza, Alexandra O. Konradi, et al.

    Highlights This review presents a systematic overview of scientific achievements in the development and use of coronary stents. It includes an analysis of key studies addressing various aspects of their performance. The article examines existing generations of coronary stents, materials used in their manufacture, design features, and also describes the latest advancements in this field.   Abstract To trace the evolution of coronary stents and identify promising directions in the development of endovascular surgery.An analytical literature review was conducted, including results from major randomized clinical trials and meta-analyses published in leading cardiology journals between 1994 and 2025.The introduction of coronary stent implantation technology reduced the incidence of thrombosis and the need for repeat revascularization compared to balloon angioplasty. However, a high risk of restenosis limited their use. The emergence of drug-eluting stents in the 2000s led to a sharp decrease in neointimal hyperplasia and repeat interventions but was associated with a risk of late thrombosis. Modern generations of stents demonstrate improved efficacy and safety. Bioresorbable stents were an innovative development but failed to show superiority in large randomized trials. Currently, stents incorporating novel anti-inflammatory agents (such as colchicine) are under development. The evolution of coronary stents reflects the pursuit of an optimal biocompatible device that induces minimal inflammatory response, promotes rapid vascular wall healing, and eliminates the need for prolonged dual antiplatelet therapy. A literature search was conducted in the PubMed electronic database for publications from 1994 to 2025. The following keywords were used: «coronary stent», «bare metal stent», «drug-eluting stent», «polymer-free», and «bioresorbable scaffold». The review included clinical studies, systematic reviews, meta-analyses, randomized controlled trials, and comparative studies relevant to the topic of analysis.


  • Open Access

    A RARE CLINICAL CASE OF BILATERAL PULMONARY VEIN ATRESIA IN NEWBORN

    by Ksenia A. Rzaeva, Ilya A. Soynov, Polina A. Kuznetsova, Elena P. Matveeva, Anna A. Lyapunova, Artem V. Gorbatykh, Ксения Асифовна Рзаева, Илья Александрович Сойнов, Полина Анатольевна Кузнецова, Елена Павловна Матвеева, et al.

    Highlights Bilateral pulmonary vein atresia is an extremely rare congenital heart disease.   Abstract Pulmonary vein atresia is a rare congenital heart defect with a high morbidity and mortality rate. This condition develops due to abnormal connections between the pulmonary veins and the left atrium. Congenital heart defect has a poor prognosis and patients die due to secondary pulmonary hypertension, hemoptysis, pulmonary edema or congestive heart failure. We report a rare case of a newborn with anomaly of pulmonary venous return: bilateral pulmonary vein aplasia.

  • Open Access

    MORPHOFUNCTIONAL FEATURES OF PULMONARY ARTERY ATRESIA WITH INTACT INTERVENTRICULAR SEPTUM AND METHODS FOR VISUALIZING DEFECTS. REVIEW ARTICLE

    by Ксения Асифовна Рзаева, Polina A. Kuznetsova, Anna A. Lyapunova, Елена Павловна Матвеева, Ilya A. Soynov, Artem V. Gorbatykh, Илья Александрович Сойнов

    Highlights Pulmonary artery atresia with intact interventricular septum is a rare congenital heart defect that depends on the ductus.   Resume Pulmonary artery atresia with intact interventricular septum is a rare and heterogeneous congenital heart disease, belonging to the group of so-called “blue” defects. The anatomical and physiological spectrum of the defect is variable with varying degrees of tricuspid valve and right ventricular hypoplasia, from a simple membranous form with a well-developed RV to severe pancreatic hypoplasia with myocardial sinusoids and right ventricular-coronary dependent blood flow. Transthoracic echocardiography is considered the “gold standard” for diagnosis, while additional imaging techniques like computed tomography and cardiac catheterization can be used to further characterize the structural features of this anomaly. In this review, we present an overview of the morphology and physiology of right-sided heart chambers in patients with pulmonary artery atresia with an intact interventricle septum.

  • Open Access

    THE 1st STAGE OF HEMODYNAMIC STRATEGIES FOR MANAGEMENT OF HYPOPLASTIC LEFT HEART SYNDROME

    by Ekaterina N. Amansakhatova, Ilya A. Soynov, Yuriy Yu. Kulyabin, Nataly R. Nichay, Kseniya A. Rzaeva, Olga S. Anikina, Ilya A. Velyukhanov, Alex N. Arkhipov, Екатерина Назаровна Амансахатова, Илья Александрович Сойнов, et al.

    Highlights The research presented in this paper evaluates the alternatives for the 1 st stage of hemodynamic correction of HLHS, outlines possible complications that may emerge in the postoperative phase, and provides approaches for their overcome in the intraoperative period. Abstract Hypoplastic left heart syndrome (HLHS) is a congenital heart disease that describes in the underdevelopment of the left-sided structures of the heart. HLHS is a rare defect in infants born and occurs in 2–3% of all congenital heart diseases. Primary heart transplantation demonstrates a radical correction of HLHS. However, a shortage of organs and a prohibition on this procedure to juvenile make it unavailable. Therefore, this review presents options for surgical correction of newborns with hypoplastic left heart syndrome, their advantages and disadvantages, as well as possible complications.

  • Open Access

    Characteristics of a self-expanding anatomically shaped valve for prosthetic replacement of the right ventricular outflow tract

    by S. N. Manukyan, I. A. Soynov, S. V. Vladimirov, D. A. Khelimsky, K. A. Rzaeva, A. V. Voytov, A. V. Gorbatykh, N. R. Nichay, Yu. Yu. Kulyabin, I. Yu. Zhuravleva, et al.

    Background . Patients following radical corrections of conotruncal congenital heart defects often develop right ventricular outflow tract dysfunctions as the child grows. It is well known that repeat surgical interventions, in addition to technical challenges, are associated with high risks and mortality. With advancements in endovascular surgery, transcatheter prosthetic right ventricular outflow tract (RVOT) replacement has become a viable alternative to thoracotomy surgery for a specific patient group. However, the choice of the "ideal" valve for transcatheter interventions remains a subject of debate. Objective . The aim of this study was to develop a valve for transcatheter implantation into the pulmonary artery position, considering anatomical variations of the RVOT, and to evaluate the hydrodynamic properties of the valve in vitro using bench testing. Material and methods . Based on the data obtained from a retrospective analysis of patients after radical correction of conotruncal congenital heart defects, a team of researchers from the Bioprosthetics Laboratory at the Center for New Surgical Technologies of National Medical Research Center n.a. Academician E.N. Meshalkin developed a prototype of a self-expanding nitinol frame for transcatheter pulmonary artery replacement. Conclusions . The prototype of the first domestically produced self-expanding pulmonary bioprosthesis for transcatheter implantation with an anatomically shaped nitinol frame demonstrated optimal hydrodynamic properties during the initial stages of preclinical testing. The anatomical design of the frame allows for valve implantation into the native right ventricular outflow tract without prior stenting.

  • Implantation of transcatheter self-expanding valve through hybrid approach: acute experiment on a large animal model

    by K.A. Rzaeva, S.N. Manukyan, A.V. Gorbatykh, I.YU. Zhuravleva, S.V. Vladimirov, I.A. Soynov

    Objective. To evaluate the properties of original transcatheter self-expanding pulmonary artery valve and to perform implantation in vivo on a large laboratory animal. Material and methods. A healthy 8-month-old female white pig weighing 66 kg underwent acute experimental procedure. Original transcatheter valve was implanted via left-sided minithoracotomy using hybrid surgical approach. Results. Immediate results revealed optimal angiographic and hemodynamic characteristics: normal closure, native pulmonary leaflets covered by the implanted bioprosthesis, no deformity of valve framework and intact pulmonary artery wall. There were no tricuspid obstruction and pressure gradient. Conclusion. Implantation of original transcatheter pulmonary artery valve in a porcine experiment demonstrated its immediate efficacy and safety without the risk of pulmonary artery perforation or displacement.

  • Transcatheter implantation of self-opening pulmonary artery valve in a preclinical animal study

    by K.A. Rzayeva, S.N. Manukyan, S.V. Vladimirov, V.P. Borodin, I.YU. Zhuravleva, A.V. Bogachev-Prokophiev, I.A. Soynov

    Objective. To evaluate early postoperative and mid-term results of transcatheter implantation of pulmonary artery valve. Material and methods. Mini-pigs ICiG were used in this preclinical study. The object of the study was transcatheter pulmonary valve bioprosthesis. We used 2 healthy white pigs (2 females) aged 12 and 14 months, respectively. Weight of pigs was 56 and 60 kg, respectively. Pulmonary valve implantation was performed through left-sided anterior mini-thoracotomy. Results. Both implantations through mini-thoracotomy were successful. Mean pressure gradient was 14 and 10 mm Hg, respectively. After 3 months, transvalvular pressure gradient was 17.6 and 14.7 mm Hg, respectively. There was no central regurgitation. We observed mild periprosthetic regurgitation in the second animal without any clinical symptoms. Conclusion. Design of new transcatheter self-opening pulmonary valve is safe and effective.

  • Long-term results of endovascular treatment of middle aortic syndrome in a child (clinical case)

    by P.A. Kuznetsova, K.A. Rzaeva, I.A. Soynov, A.A. Prokhorikhin, D.V. Alekseeva, M.A. Chernyavsky, A.V. Gorbatykh